Where does Blephex, Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Blephex, Llc ranks #23,996 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Blephex, Llc hold?

Blephex, Llc holds 11 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Blephex, Llc's Innovation Score?

Blephex, Llc has an Innovation Score of 26.7 out of 100 (top 79% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Blephex, Llc's patent grant rate increasing or decreasing?

Blephex, Llc's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Blephex, Llc's patents?

Blephex, Llc's patents average 11.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Blephex, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Blephex, Llc

Q: What technology areas does Blephex, Llc focus on?

Blephex, Llc's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 7 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Blephex ranks #23,996 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#23,996
of 50,000 US assignees by volume: Top 79%
by Innovation Score (26.7/100): 11.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23996 · US Corporation #23,996 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,996/50,000
PHOTO-FINISH Bird Group
CPC-NARROW A61F · 4 areas
INNOV-THIN 26.7/100
CLAIMS-PAR 11.0 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bird Technologies Group Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Blephex · this assignee

27
3D Lighting Innovati… · lowest

7

What this shows Blephex's Innovation Score is 26.7/100 (top 79% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Blephex's grants concentrate

Blephex, Llc is a focused PatentsView assignee: 4 CPC subclasses with 63.6% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Blephex sits between Bird Technologies Group Inc. and Blue Kai, Inc..

Blephex's three-year grant acceleration

Blephex, Llc shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bird Group

11
Birmingham

11
Black Gold Coin

11
Black Peak

11
Bloomaker USA

11
Bluvector

11
Blucher

11
Blue Kai

11
Blephex ◀

11

What this shows Blephex holds 11 patents at rank #24,013, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Blephex

By rank, the assignees closest to #24,013 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Blephex's primary technology class.

Blephex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 Top 79% higher than 21% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Blephex, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	1	9.1%
2019	1	9.1%
2020	1	9.1%
2021	1	9.1%
2023	2	18.2%
2025partial year	3	27.3%

Which technologies does Blephex, Llc patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 7

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

A61C - DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#23,996

of 50,000 tracked assignees

Innovation Score

26.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.